Afghanistan receives 500,000 doses of AstraZeneca’s COVID-19 vaccine from India

▴ Afghanistan receives 500,000 doses of AstraZeneca’s COVID-19 vaccine from India
Afghanistan has had 55,335 COVID-19 cases and 2,410 deaths from the disease, according to the health ministry.

Afghanistan received 500,000 doses of AstraZeneca’s COVID-19 vaccine from India yesterday, the first to arrive in the country.
  

The vaccines were produced by the Serum Institute of India (SII), which is producing the AstraZenecca/Oxford University vaccine for mid- and low-income countries.

Ghulam Dastagir Nazari, head of the immunisation program at the health ministry said , health workers, security force members, teachers and government employees would receive the vaccine first.
The Afghan government has already trained 1,000 people to deliver the vaccine out of the 3,000 that will be needed to carry out its vaccination drive.
 

Tags : #Afghanistan #SerumInstituteIndia #UnionHealhMinistry #AstraZeneca #OxfordUniversity #IndiaVaccineDemocracy

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sanmarg Auto++: Revolutionizing Mobility at Kolkata’s Biggest Auto FairMarch 22, 2025
39th Prof. M. Viswanathan Oration Highlights Strategies to Prevent Diabetic Foot AmputationsMarch 22, 2025
Catapulting funding crisis into opportunity by getting on track to end TB and tobacco useMarch 22, 2025
University of Leeds Opens Applications for MSc in Sustainable Agriculture & Food Production for Indian StudentsMarch 21, 2025
Crompton Reimagines Lighting with Launch of INFINIA - 20% Extra Brightness & SlimO - Ultra-Sleek Appeal!March 21, 2025
March 21, 2025
World Down Syndrome Day: Why India is Still Failing Its Special ChildrenMarch 21, 2025
The Digital Delusion: How Social Media Is Rewiring Your RealityMarch 21, 2025
Can Giving Blood Lower Your Risk of Heart Disease and Diabetes? Find OutMarch 21, 2025
Embracing Extra Chromosomes: Individuals with Down Syndrome face health challenges, stigma, and limited care, but early intervention and inclusion can transform their livesMarch 20, 2025
Why Doctors May Soon Prescribe Walks in the Park Instead of PillsMarch 20, 2025
Today some of the LIC agents met the Hon’ble Leader of Opposition and raised certain issues.March 20, 2025
Sarvodaya Healthcare, in partnership with Oncidium Foundation, becomes India’s first to offer Nuclear Therapy for cancer patientsMarch 20, 2025
Sarvodaya Healthcare, in partnership with Oncidium Foundation, becomes India’s first to offer Nuclear Therapy for cancer patientsMarch 20, 2025
Think Alcohol Is Bad for You? New Research Might Prove You WrongMarch 20, 2025
Lilly Launches Mounjaro® (tirzepatide), offering a new option for the treatment of obesity and type 2 diabetesMarch 20, 2025
How can we leave those behind who are at higher TB risk?March 20, 2025
The Global Tuberculosis Fight: Why Prevention Holds Key to EradicationMarch 20, 2025
Chew Your Way to a Sharper Mind: The Surprising Brain Hack No One Told You AboutMarch 20, 2025
Danger of substandard and falsified medical products is real and growingMarch 19, 2025